1.0Market Snapshot
- 1,479
- Pharmacy companies (1,140) and drugstore companies (339) in 2024 (BFS STATENT, NOGA 47.73 and 47.75.01). BFS counts companies, so a chain counts once; pharmaSuisse counts 1,830 pharmacy outlets (October 2025).
- 27,029
- Employees of Swiss pharmacies (22,365) and drugstores (4,664) in 2024 (BFS STATENT). Pharmacy employment is up 21.0% since 2011 while the number of pharmacy companies fell 11.3%.
- +10.8%
- Growth in pharmacy and drugstore employment from 2020 to 2024 (BFS STATENT). The Swiss pharma market grew 4.8% in the first half of 2025, driven by prescription medicines including GLP-1 weight-loss drugs (Galenica, August 2025).
According to Val Index analysis of Swiss commercial-register and federal data (2026), Switzerland counts 1,479 pharmacy & drugstore chains companies — Pharmacy companies (1,140) and drugstore companies (339) in 2024 (BFS STATENT, NOGA 47.73 and 47.75.01). BFS counts companies, so a chain counts once; pharmaSuisse counts 1,830 pharmacy outlets (October 2025)..
2.0Industry Overview
Switzerland has 1,830 pharmacies, of which 666 belong to chains and 1,164 are independent, according to pharmaSuisse (October 2025). BFS counted 1,140 pharmacy companies with 22,365 employees and 339 drugstore companies with 4,664 employees in 2024 (STATENT); because a chain counts as one company, the BFS figure is lower than the number of outlets. The industry is concentrating: there are 11.3% fewer pharmacy companies than in 2011 but 21.0% more pharmacy staff. With about 20 pharmacies per 100,000 residents, Switzerland has fewer than the European average of 31, mainly because doctors may dispense medicines themselves in many cantons.
3.0Industry Health Check (SWOT)
- Licensed, regulated market with high barriers
- Falling drug prices (index 70.3 vs 2010)
- New services: vaccination, prevention, advice
- Further federal price cuts
Unlock full Pharmacy & Drugstore Chains intelligence
Market trends, cost structure, key players, succession analysis and regional clusters for Pharmacy & Drugstore Chains — free with Market Pulse, our monthly letter on Swiss deals.
Includes one letter a month on Swiss deals. Unsubscribe anytime.
Pharmacy & Drugstore Chains business valuation in Switzerland
- Statutory Multiple (EBITDA)
- 5.0 - 7.0×
- Deal Multiple (EBITDA)
- 6.5 - 9.0×
- Market Trend
- Stable
Indicative ranges based on market research. Actual multiples vary by company size, growth, and market conditions.
8.0Regional Clusters
Western Switzerland
436 pharmacy and drugstore companies with 4,994 employees in 2024 (BFS STATENT), the most of any region, as doctors dispense less in Romandy.
Northwestern Switzerland
193 companies with 4,601 employees.
Bern and Solothurn
190 companies with 9,141 employees, a third of the national total, because Galenica, Coop Vitality and BENU are registered here and count their staff here.
Zurich
181 companies with 3,555 employees; DROPA (Zurich) and Medbase Apotheken (Winterthur) are registered here.
Ticino
174 companies with 1,333 employees, the smallest on average (7.7 per company).
Eastern Switzerland
163 companies with 1,831 employees; Zur Rose Suisse is registered in Frauenfeld.
Central Switzerland
117 companies with 1,557 employees.
Sources
9.0Frequently Asked Questions
▶How much is a pharmacy worth in Switzerland?
ValIndex's multiples table puts Swiss pharmacy retail at 6.5–9.0× EBITDA in transactions and 5.0–7.0× EBITDA on statutory valuations. Chains are the most active buyers of independent pharmacies.
▶What drives the value of a Swiss pharmacy?
Buyers price: (1) location and footfall; (2) prescription volume and customer base; (3) whether doctors nearby dispense medicines; (4) services such as vaccination; (5) staff and a licensed pharmacist to take over; (6) rent and lease terms.
▶How many pharmacies are there in Switzerland?
pharmaSuisse counts 1,830 pharmacies (October 2025), 666 in chains and 1,164 independent. BFS counted 1,140 pharmacy companies with 22,365 employees and 339 drugstore companies with 4,664 employees in 2024.
▶Who are the main Swiss pharmacy chains?
Galenica runs Amavita (196 pharmacies) and Sun Store (84) and shares Coop Vitality (86) with Coop; other chains are BENU (102), Dr. Bähler DROPA (73), Medbase (49, Migros) and Pharmacie Populaire (24) (pharmaSuisse).
▶What are the key trends in Swiss pharmacy retail?
Five trends: (1) chains gaining share; (2) fewer, larger pharmacies; (3) prescription-led growth including GLP-1 drugs; (4) falling drug prices; (5) Migros's entry through Medbase and Zur Rose.
▶What are the main risks when buying a Swiss pharmacy?
The main risks are: (1) federal price cuts; (2) doctor dispensing in the area; (3) finding a licensed pharmacist; (4) online competition; (5) lease terms. Due diligence should check prescription volumes, margins by product group, staff and the lease.
▶Is the Swiss pharmacy market growing?
Yes in volume. The Swiss pharma market grew 4.8% in the first half of 2025 and pharmacy employment rose 10.8% from 2020 to 2024, although drug prices keep falling.
▶Where are Swiss pharmacies located?
Using BFS figures for 2024: Western Switzerland has the most pharmacy and drugstore companies (436, with 4,994 employees), followed by Northwestern Switzerland (193; 4,601), Bern and Solothurn (190; 9,141, inflated by chain headquarters), Zurich (181; 3,555), Ticino (174; 1,333), Eastern Switzerland (163; 1,831) and Central Switzerland (117; 1,557).